Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288509 · ClinicalTrials.gov registry record · Phase 3
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
A Phase 3 study, sponsored by Ipsen.
- Completed
- Registry status
- Phase 3
- Development phase
- 108
- Enrollment target
NCT00288509 is a Phase 3 study that has completed, run by Ipsen. The registered enrollment target is 108 participants.
The verdict
NCT00288509, a Phase 3 study, has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 108 participants
- Enrollment target
Study Summary
The aim of this study is to assess longer term safety and effectiveness of Dysport®.
Interventions
- BIOLOGICAL Botulinum toxin type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00288509
The ClinicalTrials.gov registry entry for NCT00288509 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Botulinum toxin type A is the first listed.
NCT00288509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00288509 about?
NCT00288509 is a clinical study titled "Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia". The aim of this study is to assess longer term safety and effectiveness of Dysport®.
What is the current status of trial NCT00288509?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 108 participants. The study started on 2006-02. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00288509?
The interventions under investigation include: Botulinum toxin type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT00288509?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.